Vitafoods India 2025 ignites powerful knowledge exchange, elevating future of nutraceuticals
In India, the treatment of Cardiovascular Diseases (CVD) market is estimated to achieve a revenue of $10.52 billion by 2024. Looking ahead, the market is projected to experience a compound annual growth rate (CAGR 2024-2028)